| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.069 | 0.09 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |